Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr 14;6(1):75.
doi: 10.1186/s13287-015-0072-7.

Lipopolysaccharide preconditioning of adipose-derived stem cells improves liver-regenerating activity of the secretome

Affiliations

Lipopolysaccharide preconditioning of adipose-derived stem cells improves liver-regenerating activity of the secretome

Sang Chul Lee et al. Stem Cell Res Ther. .

Abstract

Introduction: Growing recognition of paracrine mechanisms in stem cell plasticity has resulted in considerable interest in stem cell-derived secretome. The aim of this study was to investigate the effects of lipopolysaccharide (LPS) preconditioning on the composition and hepatic regenerative activity of adipose-derived stem cell (ASC) secretome.

Methods: Conditioned medium (CM) and LPS-CM were obtained after culturing human ASCs without or with low-dose LPS (0.5 ng/mL) for 24 hours. Untreated and thioacetamide-treated mouse AML12 hepatocytes were incubated for 24 hours with the control medium, LPS (0.5 ng/mL), CM, and LPS-CM and then cell viabilities were compared. CM and LPS-CM were also intravenously administered to partially hepatectomized mice, and their effects on liver regeneration were assessed by using liver weight measurements, immunohistochemistry, and Western blotting.

Results: In the in vitro experiments, LPS preconditioning of ASCs enhanced the mRNA expression levels of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), hepatocyte growth factor, and vascular endothelial growth factor, which evoke inflammatory response or liver regeneration. LPS-CM significantly promoted thioacetamide-damaged AML12 cell viability compared with CM-incubated cells and the control cells (77%, 69%, and 65% P<0.05). In the in vivo experiment, LPS-CM infusion into the partially hepatectomized mice significantly reduced serum IL-6 and TNF-α levels compared with the other groups (P<0.05) on days 1 and 2 after partial hepatectomy. Moreover, LPS-CM infusion enhanced liver regeneration (based on the liver weight changes at day 7 after partial hepatectomy, 3.73% versus 3.22% in the CM group; P<0.05) and significantly reduced the elevated serum levels of aspartate transaminase and alanine transaminase (at day 1, P<0.05).

Conclusions: Our results suggest that LPS preconditioning effectively stimulates ASCs to produce the secretome beneficial to hepatic regeneration. Thus, optimizing ASC secretome profile by LPS preconditioning could be a promising approach to treat liver diseases by using stem cells.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effects of lipopolysaccharide (LPS) preconditioning of adipose tissue-derived stem cells (ASCs) on mRNA expression and secretion of pro-inflammatory cytokines. (A) ASCs were cultured in serum-free low-glucose Dulbecco’s modified Eagle’s medium with or without LPS in low concentration (0.5 ng/mL) for 24 hours and analyzed for mRNA expression of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), hepatocyte growth factor (HGF), and vascular endothelial growth factor (VEGF) by quantitative polymerase chain reaction. (B) Conditioned media (CM and LPS-CM) were collected, concentrated 25-fold, and analyzed for IL-6 concentration by enzyme-linked immunosorbent assay. Values represent mean ± standard deviation of four independent experiments (P <0.05). *P <0.05. CM, conditioned medium; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
Figure 2
Figure 2
Effects of conditioned medium (CM) and lipopolysaccharide (LPS)-CM on the viability of normal and hepatotoxic agent-treated mouse hepatocytes. (A) Untreated and 50 mM thioacetamide (TAA)-treated and TAA + TLR4 inhibitor (TAK-242) AML12 cells were incubated for 24 hours with the control medium, LPS (0.5 ng/mL), CM, and LPS-CM and cell viabilities were determined by using the Ez-Cytox cell viability assay. Values represent mean ± standard deviation of four independent experiments (P <0.05). (B) The expressions of phospho-signal transducer and activator of transcription 3 (p-STAT3) and STAT3 in AML12 cells treated as above were analyzed by Western blotting. *P <0.05. TLR4, Toll-like receptor 4.
Figure 3
Figure 3
Serum concentrations of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) in partially hepatectomized mice treated with adipose tissue-derived stem cell-conditioned media (CM). Mice were intravenously injected with low-glucose Dulbecco’s modified Eagle’s medium (control), lipopolysaccharide (LPS) (0.5 ng/mL), CM, or LPS-CM 1 hour after partial hepatectomy (PH) and tested for TNF-α (A) and IL-6 (B) serum levels at indicated times after PH (P <0.05). In each group, five mice were included per time interval (all 60 mice). Values represent mean ± standard deviation. *P <0.05.
Figure 4
Figure 4
Effects of conditioned medium (CM) and lipopolysaccharide (LPS)-CM on liver regeneration in partially hepatectomized mice. Mice were intravenously injected with low-glucose Dulbecco’s modified Eagle’s medium (control), LPS (0.5 ng/mL), CM, or LPS-CM 1 hour after partial hepatectomy (PH). (A) Representative micrographs show liver sections stained with anti-Ki67 antibody 24 hours after PH (magnification, 400×). (B) The percentage of Ki67-positive cells in the liver on days 1, 2, and 3 after PH (P <0.05). (C) Western blotting of liver lysates showing that the LPS-CM group had the highest expression of PCNA and p-STAT3 on day 2 after PH. (D) Liver regeneration rate (percentage) based on the ratio (percentage) of liver weight to body weight (LW/BW) on day 7 after PH; the highest regeneration was observed in the LPS-CM group (P <0.05). *P <0.05. PCNA, proliferating cell nuclear antigen; p-STAT3, phospho-signal transducer and activator of transcription 3; STAT3, signal transducer and activator of transcription 3.
Figure 5
Figure 5
Effect of conditioned medium (CM) and lipopolysaccharide (LPS)-CM on serum levels of aspartate transaminase (AST) and alanine transaminase (ALT) in partially hepatectomized mice. Mice were intravenously injected with low-glucose Dulbecco’s modified Eagle’s medium (control), LPS (0.5 ng/mL), CM, or LPS-CM 1 hour after partial hepatectomy. At day 1 after partial hepatectomy, the LPS-CM-treated mice had significantly lower AST (A) and ALT (B) levels compared with the other groups (P <0.05). *P <0.05.
Figure 6
Figure 6
Proposed mechanisms by which lipopolysaccharide-conditioned medium (LPS-CM) induces liver regeneration in partially hepatectomized mice. It can be postulated that the LPS-preconditioned secretome releases a variety of mediators-including interleukin-6 (IL-6), tumor necrosis factor-alpha, hepatocyte growth factor, and vascular endothelial growth factor—from adipose tissue-derived stem cells (ASCs) by way of intracellular nuclear factor-kappa-B (NF-κB) activation. These mediators promote hepatocyte proliferation by way of various signaling pathways, including IL-6/STAT3 signaling. JAK, Janus kinase; STAT3, signal transducer and activator of transcription 3; TLR4, Toll-like receptor 4.

Similar articles

Cited by

References

    1. Yang Z, Di Santo S, Kalka C. Current developments in the use of stem cell for therapeutic neovascularisation: is the future therapy “cell-free”? Swiss Med Wkly. 2010;140:w13130. - PubMed
    1. Schreml S, Babilas P, Fruth S, Orsó E, Schmitz G, Mueller MB, et al. Harvesting human adipose tissue-derived adult stem cells: resection versus liposuction. Cytotherapy. 2009;11:947–57. doi: 10.3109/14653240903204322. - DOI - PubMed
    1. Miura M, Miura Y, Padilla-Nash HM, Molinolo AA, Fu B, Patel V, et al. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells. 2006;24:1095–103. doi: 10.1634/stemcells.2005-0403. - DOI - PubMed
    1. Tolar J, Nauta AJ, Osborn MJ, Panoskaltsis Mortari A, McElmurry RT, Bell S, et al. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells. 2007;25:371–9. doi: 10.1634/stemcells.2005-0620. - DOI - PubMed
    1. Wang Y, Huso DL, Harrington J, Kellner J, Jeong DK, Turney J, et al. Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. Cytotherapy. 2005;7:509–19. doi: 10.1080/14653240500363216. - DOI - PubMed

Publication types

MeSH terms